Insider Trades of the Week: TransDigm, Best Buy

Round up of this week's largest insider buys and sells

Author's Avatar
Dec 17, 2016
Article's Main Image

The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to β€œ$200,000+”, duration to "December 2016” and All Insider Sales to β€œ$5,000,000+”.

According to the above filters, the following are recent buys and sells from company insiders in the past week.

Wesley R. Edens, director of Newcastle Investment Corp. (NCT), bought 2,172,000 shares for $4.15 per share on Dec. 13. Since then, the stock price has risen by 5.3% to $4.37.

The company has an institutional ownership of 37.26% and insider ownership of 3.27%. It is a real estate investment trust that focuses on opportunistically investing in and actively managing, a variety of real estate investments.

During the last 12 months, the stock price has risen by 7% and is now trading with a P/B ratio of 1.49. The price is 10.45% below its 52-week high and 71.37% above its 52-week low.

Robert J. Small, director of TransDigm Group Inc. (TDG), bought 91,978 shares of the company for $242.22 per share on Dec. 13. Since then, the stock price has risen by 2.7% to $253.98.

The company has an institutional ownership of 96.90% and an insider ownership of 0.43%. It is a designer, producer and supplier of engineered aircraft components for use on commercial and military aircraft in service.

During the last 12 months, the stock price has risen by 15% and is now trading with a P/E ratio of 24.17. The price is 13.72% below its 52-week high and 40.51% above its 52-week low.

Broadfin Healthcare Master Fun, a 10% owner of Recro Pharma Inc. (REPH), bought 650,000 shares of the company for $6.00 per share on Dec. 13. Since then, the stock price has risen by 8.7% to $6.52.

The company has an institutional ownership of 42.11% and insider ownership of 1.32%. It is a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially in the post-operative setting.

During the last 12 months, the stock price has dropped by 17% and is now trading with a P/B ratio of 1.77. The price is 47.84% below its 52-week high and 16.64% above its 52-week low.

Most important sales of the week

Walter W. Bettinger, president and CEO of Charles Schwab Corp. (SCHW), sold 206,092 shares in the company for $39.85 per share on Dec. 15. Since then, the stock price has dropped by 1.1% to $39.42.

The company has an institutional ownership of 75.08% and insider ownership of 0.26%. It is a savings and loan holding company, which through its subsidiaries is engaged in securities brokerage, banking and related financial services. It operates in two segments, Investor Services and Advisor Services.

During the last 12 months, the stock price has risen by 17% and is now trading with a P/B ratio of 3.87. The price is 1.35% below its 52-week high and 83.26% above its 52-week low.

Richard M. Schulze, 10% owner of Best Buy Co. Inc. (BBY), sold 235,000 shares in the company for $48.50 per share on Dec. 15. Since then, the stock price has dropped by 0.7% to $48.16.

The company has an institutional ownership of 85.89% and insider ownership of 1.74%. It is a retailer of technology products, including tablets and computers, televisions, mobile phones, large and small appliances, entertainment products, digital imaging and related accessories.

During the last 12 months, the stock price has risen by 57% and the price is 2.51% below its 52-week high and 90.28% above its 52-week low.

David C. Hodgson, director and 10% owner of Trinet Group Inc. (TNET), sold 2,400,000 shares in the company for $24.03 per share on Dec. 14. Since then, the stock price has risen by 1.2% to $24.59.

The company has an insider ownership of 1.44% and institutional ownership of 77.77%. It is a provider of a human resources solution for small to medium-sized businesses. Its HR solution includes services such as payroll processing, human capital consulting, employment law compliance and employee benefits.

During the last 12 months, the stock price has risen by 33% and is now trading with a P/B ratio of 58.87. The price is 7.07% below its 52-week high and 121.53% above its 52-week low.

Disclosure: I do not own any shares of any stocks mentioned in this article.

Start a free seven-day trial of Premium Membership to GuruFocus.Γ‚